Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pommier

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Journal of Contemporary Brachytherapy|February 23, 2023
Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO membersManon Kissel, Luc Ollivier, Ingrid Fumagalli, et al.
Plos One|December 1, 2017
Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)David Pasquier, Philippe Nickers, Didier Peiffert, et al.
Journal of Contemporary Brachytherapy|October 6, 2022
Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patientsFlorent Guillemin, Anne-Agathe Serre, Frédéric Gassa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2005
Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocolPascal Pommier, Luciano Zucca, Ingemar Näslund, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 12, 2024
Ultra-hypofractionated prostate cancer radiotherapy: Dosimetric impact of real-time intrafraction prostate motion and daily anatomical changesFrancesca di Franco, Thomas Baudier, Pierre Marie Pialat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2008
Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03)Laetitia Tournier-Rangeard, Mariette Mercier, Didier Peiffert, et al.
Anti-Cancer Drugs|March 12, 2010
Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institutionJérôme Fayette, Anthony Montella, Sylvie Chabaud, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2009
A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neckGuillaume Buiret, Claire Combe, Véronique Favrel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 11, 2025
Best practice in brachytherapy: 2025 updateJean-Michel Hannoun-Lévi, Sophie Renard, Pascal Pommier, et al.
Drug Design, Development and Therapy|December 10, 2015
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinomaJérôme Fayette, Yann Molin, Emilie Lavergne, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Journal of Contemporary Brachytherapy|February 23, 2023
Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO membersManon Kissel, Luc Ollivier, Ingrid Fumagalli, et al.
Plos One|December 1, 2017
Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)David Pasquier, Philippe Nickers, Didier Peiffert, et al.
Journal of Contemporary Brachytherapy|October 6, 2022
Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patientsFlorent Guillemin, Anne-Agathe Serre, Frédéric Gassa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2005
Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocolPascal Pommier, Luciano Zucca, Ingemar Näslund, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 12, 2024
Ultra-hypofractionated prostate cancer radiotherapy: Dosimetric impact of real-time intrafraction prostate motion and daily anatomical changesFrancesca di Franco, Thomas Baudier, Pierre Marie Pialat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2008
Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03)Laetitia Tournier-Rangeard, Mariette Mercier, Didier Peiffert, et al.
Anti-Cancer Drugs|March 12, 2010
Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institutionJérôme Fayette, Anthony Montella, Sylvie Chabaud, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2009
A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neckGuillaume Buiret, Claire Combe, Véronique Favrel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 11, 2025
Best practice in brachytherapy: 2025 updateJean-Michel Hannoun-Lévi, Sophie Renard, Pascal Pommier, et al.
Drug Design, Development and Therapy|December 10, 2015
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinomaJérôme Fayette, Yann Molin, Emilie Lavergne, et al.
Pageof 12